Susquehanna Portfolio Strategies, LLC
Position in ADCT — ADC Therapeutics SA
CIK 1996449
Bala Cynwyd, PA
Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$241,961
+$14,195 QoQ
Shares Held
64,523
0.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Susquehanna Portfolio Strategies, LLC holds $45,181,359 across 9 Drug Manufacturers - Specialty & Generic names. ADCT ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
184,035 | $24,244,770 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
142,182 | $7,349,387 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
328,003 | $4,077,077 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
374,016 | $3,560,632 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4,594 | $2,724,150 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
26,750 | $1,479,542 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
156,443 | $1,298,476 | |
| 8 | ADCT |
ADC Therapeutics SA
This page
|
64,523 | $241,961 |
All Filings in ADCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $241,961 | 64,523 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $227,766 | 64,523 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $258,092 | 64,523 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $116,381 | 43,426 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||